Weisser B, Lieder P, Göbel B, Vetter H, Düsing R
Medical University-Policlinic, Bonn, Federal Republic of Germany.
Int J Clin Pharmacol Res. 1990;10(6):325-30.
The mechanisms responsible for the resetting of the baroreceptor reflex during long-term administration of 1,4 dihydropyridine calcium channel blockers are incompletely understood. The present study investigated the effect of 10 mg per day of felodipine on arterial blood pressure (BP), heart rate (HR), urinary norepinephrine, and cardiac beta-1-receptor sensitivity in 10 healthy volunteers. Blood pressure heart rate and urinary norepinephrine were determined during control and on days 1,4, and 14 of felodipine administration. Dose response curves of intravenous bolus injections of isoproterenol were performed on the same days to measure cardiac beta-1-receptor sensitivity. Felodipine significantly reduced the blood pressure from 131 +/- 6/74 +/- 3 mm Hg (mean +/- s.e.m.) to 123 +/- 6/65 +/- 2 mm Hg on day 1 (p less than 0.01). The blood pressure remained decreased during the entire protocol. The initial increase in the heart rate (62 +/- 5 to 67 +/- 4 min-1) remained elevated on day 4 and returned within the control range by day 14 (63 +/- 4 min-1) in spite of unchanged felodipine plasma levels (1.71 +/- 1.13 ng/ml (day 1) and 1.66 +/- 0.66 ng/ml (day 14). Urinary norepinephrine rose significantly with short-term felodipine administration (62 +/- 12 versus 50 +/- 6 micrograms/24 h; p less than 0.01). With long-term felodipine administration this value returned to pretreatment levels (55 +/- 12 micrograms/24 h). Cardiac beta-1-receptor sensitivity was not changed at any point of the protocol.(ABSTRACT TRUNCATED AT 250 WORDS)
长期服用1,4 - 二氢吡啶类钙通道阻滞剂期间压力感受器反射重置的机制尚未完全明确。本研究调查了每天10毫克非洛地平对10名健康志愿者动脉血压(BP)、心率(HR)、尿去甲肾上腺素及心脏β1受体敏感性的影响。在对照期以及非洛地平给药的第1、4和14天测定血压、心率和尿去甲肾上腺素。在同一天进行静脉推注异丙肾上腺素的剂量反应曲线测定,以测量心脏β1受体敏感性。非洛地平在第1天显著降低血压,从131±6/74±3毫米汞柱(平均值±标准误)降至123±6/65±2毫米汞柱(p<0.01)。在整个实验过程中血压持续下降。尽管非洛地平血浆水平未变(第1天为1.71±1.13纳克/毫升,第14天为1.66±0.66纳克/毫升),心率最初从62±5次/分钟增至67±4次/分钟,在第4天仍保持升高,到第14天恢复至对照范围(63±4次/分钟)。短期服用非洛地平后尿去甲肾上腺素显著升高(62±12对50±6微克/24小时;p<0.01)。长期服用非洛地平后该值恢复至治疗前水平(55±12微克/24小时)。在实验过程中的任何时间点,心脏β1受体敏感性均未改变。(摘要截选至250字)